New England Journal of Medicine · 2015 · 1.6K citations · 24 references
MedicineInternal MedicineOutcomes ResearchResuscitationSepsisCardiopulmonary ResuscitationFluid ResuscitationSepsis ManagementSeptic ShockShock ManagementClinical Outcome MeasurementCost-effectiveness Analysis PerspectiveEarly Goal-directed TherapyPragmatic Trial DesignPrehospital Fluid ResuscitationPrimary Outcome AnalysisResuscitation Fluid TherapySeptic Shock Management
Early, goal‑directed therapy is recommended by international guidelines for resuscitating patients with early septic shock. To evaluate the effectiveness and cost‑effectiveness of EGDT versus usual care in a pragmatic randomized trial across 56 English hospitals. Patients were randomized to a 6‑hour EGDT protocol or usual care, with 1260 participants (630 per arm). EGDT did not reduce 90‑day mortality (29.5% vs 29.2%, RR 1.01, 95% CI 0.85–1.20) and was associated with higher fluid, vasoactive, and transfusion use, worse organ‑failure scores, longer ICU stays, no improvement in secondary outcomes, and higher costs with <20% probability of cost‑effectiveness. The study was funded by the UK National Institute for Health Research Health Technology Assessment Programme (ISRCTN36307479).
Early, goal-directed therapy (EGDT) is recommended in international guidelines for the resuscitation of patients presenting with early septic shock. However, adoption has been limited, and uncertainty about its effectiveness remains.We conducted a pragmatic randomized trial with an integrated cost-effectiveness analysis in 56 hospitals in England. Patients were randomly assigned to receive either EGDT (a 6-hour resuscitation protocol) or usual care. The primary clinical outcome was all-cause mortality at 90 days.We enrolled 1260 patients, with 630 assigned to EGDT and 630 to usual care. By 90 days, 184 of 623 patients (29.5%) in the EGDT group and 181 of 620 patients (29.2%) in the usual-care group had died (relative risk in the EGDT group, 1.01; 95% confidence interval [CI], 0.85 to 1.20; P=0.90), for an absolute risk reduction in the EGDT group of -0.3 percentage points (95% CI, -5.4 to 4.7). Increased treatment intensity in the EGDT group was indicated by increased use of intravenous fluids, vasoactive drugs, and red-cell transfusions and reflected by significantly worse organ-failure scores, more days receiving advanced cardiovascular support, and longer stays in the intensive care unit. There were no significant differences in any other secondary outcomes, including health-related quality of life, or in rates of serious adverse events. On average, EGDT increased costs, and the probability that it was cost-effective was below 20%.In patients with septic shock who were identified early and received intravenous antibiotics and adequate fluid resuscitation, hemodynamic management according to a strict EGDT protocol did not lead to an improvement in outcome. (Funded by the United Kingdom National Institute for Health Research Health Technology Assessment Programme; ProMISe Current Controlled Trials number, ISRCTN36307479.).
24
R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes et al. · Critical Care Medicine · 2013 · 9.7K citations
Veterinary Medicine, Infectious Diseases, Internal Medicine +9